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The adverse environmental impact of
organochlorine pesticides has led to their
gradual replacement with less damaging alter-
natives, notably the organophosphates.
Chlorpyrifos (O,O-diethyl O-3,5,6-trichloro-
2-pyridyl phosphorothioate) is one of the
most widely used organophosphates, largely
because of its stability and persistence.
Recently, however, a new concern has arisen
about exposure of pregnant women and chil-
dren (1–3), and in the United States limita-
tions have been placed on domestic use,
where exposures may be particularly high
(4–7). Its major use in agriculture or other
professional applications remains unabated
throughout the world and represents a grow-
ing dilemma for storage and disposal.
The acute systemic toxicity of organo-
phosphates reflects cholinergic hyperstimula-
tion due to inhibition of cholinesterase; in
the case of chlorpyrifos, this action is pro-
duced by its active metabolite, chlorpyrifos
oxon. However, it is increasingly clear that
the developmental neurotoxicity of chlor-
pyrifos comprises other actions of the native
compound itself (2,3,8–16). In vivo studies
with developing rodents have identified sev-
eral processes targeted by chlorpyrifos,
including neural cell replication (8,11), neu-
rite outgrowth (16), signaling cascades and
transcriptional events involved in neural cell
differentiation (9,12), oxidative stress
(14,17,18), and cell damage and apoptosis
(19,20), all of which culminate in altered
synaptic neurotransmission (21–25) and
consequent behavioral anomalies (13,24).
Indeed, both chlorpyrifos and chlorpyrifos
oxon are capable of direct actions on mus-
carinic and nicotinic cholinergic receptors,
influencing second messenger production
(26–28) and ion fluxes (29,30); hence, even
some of the cholinotypic actions on develop-
ing systems may be mechanistically unre-
lated to inhibition of cholinesterase activity.
The problems inherent with in vivo
treatments—such as maternal toxicity, alter-
ations in the physiology of the maternal-fetal
unit, hormonal imbalances, or changes in
metabolism and nutrition—have rendered it
difficult to identify the actual cellular targets
of chlorpyrifos in the developing brain.
Consequently, attempts have been made to
model the effects in vitro, using either trans-
formed cell lines with neurotypic features
(11,12,14,16–18,31–33) or cultures of
immature brain tissue (15,19,34). These
approaches share a different set of limita-
tions. Transformed cell lines are not identi-
cal to neural cells and are not only typically
less responsive to neurotoxins such as chlor-
pyrifos (11) but, as transformed cells, have
abnormal replication and differentiation pat-
terns. Furthermore, a single cell line cannot
recapitulate the cell-to-cell signaling events
that are likely to be targeted by chlorpyrifos
in the developing brain in vivo, most notably
cholinergic and monoaminergic neurotrans-
mission (2,3,21–23,35) and transduction
components such as the protein kinases that
are linked to these transmitters (9,26–28,36).
Aggregating cultures of mixed neuronal and
glial cells (15), micromass cultures from fetal
brain regions (34), or cultured embryos (19)
may obviate the problem of single-cell cul-
tures, but are limited in their applicability
only to short periods of development,
whereas the actions of chlorpyrifos are likely
to extend over a broad temporal range
(1–3,37–40).
It would thus be extremely worthwhile to
develop a model system that encompasses
development across multiple stages and that
requires cell-to-cell communication specifically
involving cholinergic and monoaminergic
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Chlorpyrifos targets mammalian brain development through a combination of effects directed at
cholinergic receptors and intracellular signaling cascades that are involved in cell differentiation.
We used sea urchin embryos as an invertebrate model system to explore the cellular mechanisms
underlying the actions of chlorpyrifos and to delineate the critical period of developmental vul-
nerability. Sea urchin embryos and larvae were exposed to chlorpyrifos at different stages of devel-
opment ranging from early cell cleavages through the prism stage. Although early cleavages were
unaffected even at high chlorpyrifos concentrations, micromolar concentrations added at the mid-
blastula stage evoked a prominent change in cell phenotype and overall larval structure, with
appearance of pigmented cells followed by their accumulation in an extralarval cap that was
extruded from the animal pole. At higher concentrations (20–40 µM), these abnormal cells con-
stituted over 90% of the total cell number. Studies with cholinergic receptor blocking agents and
protein kinase C inhibitors indicated two distinct types of effects, one mediated through stimula-
tion of nicotinic cholinergic receptors and the other targeting intracellular signaling. The effects
of chlorpyrifos were not mimicked by chlorpyrifos oxon, the active metabolite that inhibits
cholinesterase, nor by nonorganophosphate cholinesterase inhibitors. Dieldrin, an organochlorine
that targets GABAA receptors, was similarly ineffective. The effects of chlorpyrifos and its under-
lying cholinergic and signaling-related mechanisms parallel prior findings in mammalian embry-
onic central nervous system. Invertebrate test systems may thus provide both a screening
procedure for potential neuroteratogenesis by organophosphate-related compounds, as well as a
system with which to uncover novel mechanisms underlying developmental vulnerability. Key
words: acetylcholine, chlorpyrifos, cholinergic receptors, development, dieldrin, GABA, neurotox-
icity, organophosphate pesticides, sea urchin. Environ Health Perspect 109:651–661 (2001).
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neurotransmitters and their signaling cas-
cades. Ideally, the system could then be used
to identify specific cellular mechanisms for
the actions of chlorpyrifos, notably the
cholinergic receptors and appropriate signal-
ing cascades, as well as potentially providing
a screening mechanism with which to com-
pare chlorpyrifos to other organophosphates
or alternative classes of pesticides. 
In the current study, we have explored
the sea urchin embryo and larva as a test sys-
tem. In the course of ontogeny, the sea
urchin, like the mammalian central nervous
system (CNS), develops a functional cholin-
ergic response system, comprising the requi-
site receptors and signaling cascades, with
expression of these components evolving
over a defined developmental period sur-
rounding cell differentiation and morpho-
logical assembly (41,42). Thus, events
involved in neuroteratogenicity in the mam-
malian brain are paralleled by “pre-nervous”
morphogenetic anomalies in the developing
sea urchin (42–48). Importantly, sea urchin
embryos are unaffected by cholinesterase
inhibition per se; thus, in them we can
examine developmental mechanisms, includ-
ing those involving cholinergic systems, that
are distinct from those associated with anti-
cholinesterase actions, the effects that under-
lie the systemic toxicity of organophosphates
in mammals (41,44,47,49). Additionally,
the normal morphologic and biochemical
features of sea urchin embryonic and larval
development are well characterized, as are
the classes of developmental malformations
evoked by a wide variety of embryotoxins
and teratogens (43,46,50,51), so the effects
of chlorpyrifos or other pesticides can be
compared mechanistically to compounds
with defined mechanisms of action.
Besides using the sea urchin to identify
the developmental processes affected by chlor-
pyrifos exposure, we have characterized the
temporal events that define the critical period
of vulnerability and, by identifying specific
cell signaling targets, have performed a pre-
liminary evaluation of potential antidotes that
might prevent developmental toxicity. We
also contrasted the effects of chlorpyrifos with
those of the organochlorine pesticide dieldrin,
which targets GABAA receptors (52,53), to
determine whether the actions of the
organophosphate represents selective effects,
as opposed to more general developmental
toxicity shared by other pesticide classes.
Materials and Methods
Sea urchins Strongylocentrotus droebachiensis
and S. purpuratus were trawled or captured
using SCUBA near Friday Harbor,
Washington, USA. They were maintained
up to 4–6 months with their normal food
(kelp) in aquaria with continuously flowing
sea water (8–10°C) at Friday Harbor
Laboratories. The techniques of insemination
and handling of embryos and larvae were
conducted as reported previously (51). We
obtained the eggs or sperm by injecting the
ripe animals with 0.8–1.0 mL (S. droe-
bachiensis) or 0.3–0.5 mL (S. purpuratus) of
0.55 M KCl. Some animals were re-injected
after about 20 days. Artificial sea water
(ASW; 445 mM NaCl, 24.6 mM MgCl2,
18.1 mM MgSO4, 9.2 mM KCl, 2.36 mM
NaHCO3, 11.5 mM CaCl2; pH 7.5) was
used as the incubation medium. The suspen-
sions of unfertilized eggs were passed through
a nylon mesh for elimination of the jelly coat.
We obtained embryos and larvae by fer-
tilizing eggs from 19 females of S. droe-
bachiensis (28 batches) and 9 females of S.
purpuratus (14 batches) and placed them in
multiwell cell culture plates. Test substances
were introduced into the wells approxi-
mately 30 min after the insemination of the
eggs (one-cell stage) or later, at the mid-blas-
tula, late (mesenchyme) blastula, gastrula, or
prism stages. Suspensions varied from 40 to
60 (S. droebachiensis) or 100 to 150 (S. pur-
puratus) per mL and were approximately the
same for all treatments and across experi-
ments. Embryos and larvae in control wells
were incubated in pure ASW and in ASW
with corresponding quantities of vehicles
(distilled water, methanol, or ethanol—see
below). The final incubation volume was 1
or 2 mL and the temperature was main-
tained at approximately 10°C. Embryonic
and larval development were viewed in a
microscope and videotaped using a video
camera. Images were transferred to a video
cassette recorder and then digitized. The
videotaping was sometimes performed
throughout an experiment at intervals of
4–24 hr or, more often, at the end of an
experiment, when the treated embryos or
larvae displayed maximally abnormal pheno-
types. Initially all embryos or larvae in a
given well were videotaped at low (40×)
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Figure 1. Effects of chlorpyrifos introduced at the mid-blastula 2 stage (25 hr 30 min after fertilization, 10ºC)
on the development of sea urchin S. droebachiensis. Videotaping was done 62 hr after fertilization. (A)
Chlorpyrifos 20 µM; mushroom-like larvae, defect category III (see Table 1). (B) Chlorpyrifos 0.5 µM; virtu-
ally normal larvae at the prism stage, category 0. Scale bar = 200 µM.
Figure 2. Structural formulae of lipophilic acetyl-
choline antagonists.
Figure 3. Dieldrin does not change the development of sea urchin S. droebachiensis. (A) Dieldrin; 100 µM
was given 30 min after fertilization. (B) ASW; the larvae were videotaped 5 days 22 hr after fertilization;
note the normal plutei in both cases. Scale bar = 100 µm.
magnification (Figure 1). For nearly every
treatment paradigm, all (100%) specimens
showed the same phenotype, so representa-
tive specimens were imaged at higher magni-
fication (100× or 200×) for presentation.
The following substances were tested (the
concentration of stock solution and vehicle
used are given in parentheses): dieldrin (40
mM in ethanol or DMSO) and chlorpyrifos
(20 mM in methanol) (both from Chem
Service, West Chester, PA, USA); chlorpyrifos
oxon and 3,5,6-trichloropyridinol (both 40
mM in methanol) supplied by the U.S.
Environmental Protection Agency (Research
Triangle Park, NC, USA); imechine (Latoxan,
Valence, France), a hydrophilic antagonist of
neuronal nicotinic acetylcholine receptors
(nAChR), and the noncompetitive antago-
nist QX-222 (Astra Pharmaceuticals,
Westborough, MA, USA) (both at 20 mM in
distilled water); atropine sulfate (RBI,
Natick, MA, USA), a muscarinic acetyl-
choline receptor antagonist (40 mM in
distilled water); 1-(5-isoquinolinesulfonyl)-2-
methylpiperazine (H-7), an inhibitor of
protein kinase (PK) C, and N-(2-guanidi-
noethyl)-5-isoquinolinesulfonamide (HA-
1004), an inhibitor of PKA (both from RBI,
and each at 20 mM in distilled water).
In addition, we tested two novel deriva-
tives of polyunsaturated fatty acids:
dimethylaminoethyl esters of arachidonic
and docosahexaenoic acids (AA-DMAE,
26.6 mM, and DHA-DMAE, 25 mM in
ethanol). These new compounds (Figure 2)
were synthesized in the Laboratory of
Oxylipins, Shemyakin-Ovchinnikov Institute
of Bioorganic Chemistry, Moscow (54,55).
Based on our recent results (55,56),
AA-DMAE and DHA-DMAE act on sea
urchin embryos and larvae as antagonists of
acetylcholine receptors. Because of their
high lipophilicity, these substances penetrate
the cytoplasm of embryonic or larval cells to
act on both intracellular and cell surface
receptors. This is potentially critical to the
current model because the coexistence of
intracellular and surface-located transmitter
receptors is typical for sea urchin embryos
and early larvae (45).
The final concentrations of all substances
were prepared in ASW. Vehicle-treated
embryos and larvae developed completely
normally up to the end of the observation
period at the onset of active feeding; the
highest final concentrations of vehicles were
0.2–0.4% by volume. All comparisons show
chlorpyrifos- or drug-exposed embryos and
larvae juxtaposed to the comparable, vehicle-
treated control group.
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Table 1. Effects of chlorpyrifos on S. droebachiensis.
Chlorpyrifos added Chlorpyrifos added 
Chlorpyrifos added 30 min after fertilization 24–30 hr after fertilizationa 43–46 hr after fertilizationb
Evaluated 22 hr after Evaluated 32 hr after Evaluated 54–60 hr after Evaluated 64–68 hr after 
fertilizationc fertilizationd fertilizatione fertilizationf
No. of Defect No. of Defect No. of Defect No. of Defect
Chlorpyrifos (µM) embryos category embryos category larvae category larvae category
0 680 0 680 0 3,260 0 785 0
0.2–0.5 — — — — 300 0 — —
1–2 — — — — 2,080 0–I* — —
2.5–5 500 0 500 0 2,250 I 710 0
10 495 0 495 0 2,045 II 760 0
15 520 0 520 I 1,980 II 725 I
20 510 0 510 I 2,340 III 720 II
30 510 0 510 II 2,080 III — —
40 525 0 525 III 2,175 IV 705 III
80 500 0 500 IV 2,250 IV 720 IV
160 510 0 510 IV — — — —
Total n/total no. 4,750/5 4,750/5 20,800/22 5,125/9
of experiments
Defect category (type of malformation), as illustrated in Figures 1, 4–10: 0 – no malformations; I – weak (Figure 5B); II - moderate (Figure 7A,C); III – strong (Figures 1A, 4H, 6A, 9C, 10C); IV
– maximum (Figures 5A, 9A). In each defect category, n = number of embryos or larvae 100% of which showed malformation, except where indicated: 0–I* = 1,510 larvae with defect I;
570 with no defects.
aMid-blastula 2 to late blastula 1 stages. bGastrulation. cMid-blastula 1. dLate blastula 1 or 2. eLate gastrula–early prism. fPrism.
Table 2. Effects of chlorpyrifos on S. purpuratus.
Chlorpyrifos added Chlorpyrifos added  
Chlorpyrifos added 30 min after fertilization 25 hr after fertilizationa 45 hr after fertilizationb
Evaluated 24 hr after Evaluated 32–36 hr after Evaluated 45–55 hr after Evaluated 62 hr after
fertilizationc fertilizationd fertilizatione fertilizationf
No. of Defect No. of Defect No. of Defect No. of Defect
Chlorpyrifos (µM) embryos category embryos category larvae category larvae category
0 1,560 0 1,560 0 3,115 0 1,920 0
1 — — — — 2,485 0–I** — —
2.5 1,120 0 1,120 0 2,500 0–I* — —
5 1,125 0 1,125 0 2,640 I 1,410 0
10 1,040 0 1,040 0 2,680 II 1,540 0
15 1,040 0 1,040 I 2,255 II 1,435 I
20 1,285 0 1,285 I 2,385 III 1,520 II
30 1,050 0 1,050 II 2,580 III — —
40 1,280 0 1,280 III 2,840 IV 1,485 III
80 1,160 0 1,160 IV 2,600 IV 1,480 IV
160 1,180 0 1,180 IV — — — —
Total n/total no. 11,840/5 11,840/5 28,760/11 10,790/6
of experiments
As in Table 1, except: 0–I* = 1,420 larvae with defect I; 1,080 larvae with no defects. 0–I** = 560 larvae with defect I; 1,925 with no defects.
aMid-blastula 2 stage. bGastrulation. cMid-blastula 1. dLate blastula 2 to early gastrula 1. eLate gastrula–early prism. fPrism.
In additional experiments to assess the
stability of chlorpyrifos oxon in ASW, we
prepared chlorpyrifos oxon as a 40 mM stock
solution in methanol and then added it to
ASW to achieve a final concentration of 40
µM, which was incubated for 24 hr at 10°C.
Aliquots were taken immediately after addi-
tion of the chlorpyrifos-oxon, and after 3 and
24 hr of incubation. Extractions and analysis
were performed as described earlier (57).
Results
Effects of dieldrin and chlorpyrifos. In 14
experimental series on S. droebachiensis (14
batches of eggs obtained from 9 females) and
6 series on S. purpuratus (6 batches from 6
females), dieldrin at all concentrations
(10–200 µM) had little or no effect on
embryonic or larval development up to the
start of active feeding, at which point obser-
vations were discontinued (Figure 3).
Similar, negative results were obtained when
dieldrin was introduced at any stage of
development from one-cell up to the prism
stage. Judged by standard larval behavioral
criteria, e.g., swimming activity, the nervous
system of the dieldrin-treated larvae
appeared to function normally. At the high-
est nominal concentrations of dieldrin
(100–200 µM), its actual concentration in
ASW may be limited by its low solubility.
In contrast to dieldrin, chlorpyrifos
evoked marked concentration- and stage-
dependent developmental anomalies, identi-
cal for both sea urchin species (22 batches
from 16 females of S. droebachiensis and 11
batches from 7 females of S. purpuratus). A
summary of the results, along with the
numbers of embryos and larvae for each
treatment paradigm appears in Tables 1 and
2. However, because the embryos of S. pur-
puratus are smaller and highly pigmented, we
present pictures only of representative
embryos and larvae of S. droebachiensis in the
figures illustrating the defects (Figures 4–10).
We evaluated three different treatment
paradigms (Tables 1 and 2): chlorpyrifos
added 30 min after fertilization, added at the
mid-blastula 2 to late blastula 1 stage (24–30
hr after fertilization), or added at gastrulation
(43–46 hr after fertilization). Evaluations
were then conducted at the mid-blastula 1
stage, late blastula 1 or 2 through early gas-
trula 1 stage, late gastrula–early prism stage,
or prism stage; the characteristics of each
stage have been described previously (51).
When we added chlorpyrifos 30 min after
fertilization and examined embryos at the
mid-blastula 1 stage (22 hr after fertilization),
we did not observe any defects, even at very
high concentrations (160 µM). When we
examined these same embryos 10 hr later, at
the late blastula 1 or 2 stage, every embryo
exposed at a concentration of 15 µM or
higher displayed developmental anomalies,
with the type of defect intensifying as the
concentration was raised. Accordingly, we
next examined a later exposure paradigm
(chlorpyrifos added 24–30 hr after fertiliza-
tion) begun at mid-blastula 2 through late
blastula 1—i.e., from the last stages of
embryonic development (when embryos
begin to rotate inside the fertilization enve-
lope because of ciliary beating, and are hatch-
ing) to the first larval stage. This later
exposure period exhibited the maximum
sensitivity to chlorpyrifos, with anomalies
present at only 1–2 µM. Sensitivity then
declined, so exposure begun 46 hr after
fertilization (during gastrulation) was less
effective. Therefore, for evaluations of the
concentration threshold, or for interactions
with blocking agents or metabolic inhibitors,
we performed most studies using exposure
begun at the mid-blastula 2 to late blastula 1
stage. Because we obtained a high incidence
of anomalies (75%) at 1–2 µM chlorpyrifos,
we performed preliminary experiments on S.
droebachiensis and found some anomalies at
even lower concentrations (between 0.5 and
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Figure 4. Effects of chlorpyrifos introduced at the late blastula 1 stage (30 hr after fertilization, 10ºC) on the
development of sea urchin S. droebachiensis. (A) Chlorpyrifos 40 µM, 36 hr after fertilization. (B) The same
as (A), 1 hour 30 min later. (C) Control, 36 hr after fertilization. (D) Chlorpyrifos 20 µM, 39 hr 15 min after fer-
tilization. (E) The same sample as (D), 2 hr 45 min later. (F) Control, 39 hr 15 min after fertilization. (G)
Chlorpyrifos 20 µM, 46 hr after fertilization. (H) The same sample as (G), 1 hr 30 min later. (I) Control, 46 hr
after fertilization. Structural features are shown as follows: 1, blastopore; 2, archenteron (primary gut); 3,
cells accumulated in the blastocoel; 4, extralarval cells; 5, extralarval conglomerate of pigmented cells
(mushroom-like “cap”); arrows without numbers, cells of primary or secondary mesenchyme. Scale bar =
50 µm. 
1 µM), similar to thresholds seen in mam-
malian cell cultures or embryos (11,12,14,
16,19,34). At slightly higher concentrations
(2.5–5 µM and above), every one of the
thousands of embryos or larvae receiving
chlorpyrifos treatment displayed develop-
mental anomalies (Tables 1 and 2, Figure 1);
the morphological characteristics of each type
of anomaly are described below.
After introduction of 20–40 µM chlor-
pyrifos during the period of maximum sensi-
tivity (late blastula 1 stage, 30 hr after
fertilization) anomalies became evident by
the early gastrula stage, 5–6 hr after addition
of chlorpyrifos (Figure 4). Beginning at that
time, the number of mesenchyme cells
migrating into the blastocele was increased
above normal levels. These cells then started
to darken, losing their transparency (Figure
4A, B), and became located along the inner
surface of the body wall; in contrast, cells in
normal larvae retained their transparency
and were located near the primary gut
(archenteron), moving later through the
blastocele to the animal pole (Figure 4C, F).
One or 2 hr later, the darkened cells of
chlorpyrifos-exposed larvae began to show
extrusion from the animal pole (extrusion,
not proliferation—see below). During the
next 2–3 hr the number of extruded cells
increased sharply. We conducted prelimi-
nary estimates of the proportions of cells
affected by measuring the relative area of
extralarval cell conglomerates for all larvae
treated with a given concentration of chlor-
pyrifos. Cell sizes in the conglomerates
appeared to be similar to those in nontrans-
formed parts of the larvae. Using this estima-
tion, approximately 50% or more of all
larval cells were extruded, maintaining, as
earlier, their dark pigmentation (Figure 4D,
E). Over the subsequent few hours, the
number of extruded cells continued to rise,
eventually comprising up to 80–90% of the
total (Figure 4G, H). In contrast, there were
never any signs of cell extrusion during the
development of control larvae (Figure 4F, I).
As a result of chlorpyrifos treatment in
this sensitive period, a compact extralarval
cap, largely comprised of pigmented cells,
formed at the animal pole, and the blastocele,
indeed the larva itself, was correspondingly
diminished because of both cell extrusion
and compaction. The size of the caps of these
mushroom-shaped larvae showed a direct
correspondence to the chlorpyrifos concen-
tration. At high concentrations (40–80 µM),
the cap often enveloped nearly the entire
larva and contained more than 90% of total
cells (Figure 5A), resulting in death within a
few hours (defined as a maximal defect, cate-
gory IV in Tables 1 and 2). At 20–30 µM
(Figures 4 and 6), the larvae remained
motile, retained the blastopore and the lower
part of archenteron and generally survived
through the next 1–2 days; they did not lose
their extralarval caps (category III). With a
further reduction to 15 µM chlorpyrifos, the
fully developed caps were smaller, comprising
only 40–60% of all cells, and were round in
appearance, delimited very clearly from the
larva itself (Figure 6B). In this case, the caps
sometimes were lost because of ciliary beat-
ing, and larvae that lost their caps continued
to develop for the ensuing 1–2 days; how-
ever, we did not follow their ultimate fate.
Regardless of whether they retained or lost
the cap, most of the chlorpyrifos-exposed lar-
vae began to exogastrulate and thus became
nonviable (category II).
With a further decrement in the concen-
tration of chlorpyrifos (5–10 µM) we observed
the formation of much smaller extralarval caps
(see Figure 10A, below). Typically, these caps
were lost during development and hence the
larvae retained some viability (a variant of cate-
gory II). Accordingly, with this treatment
group, we were able to delineate the anatomi-
cal features of the extralarval cell caps. Before
its loss, the cap was connected to the animal
pole of the larva by a thin stalk. In fact, the
whole animal surface of the larva was intact
and covered by cilia after the loss of the cap,
implying that the cap was really an extralarval
abnormal structure, not part of the larva itself.
At even lower chlorpyrifos concentrations
(2.5–5 µM), there was no extrusion of cells
from the blastocele. Instead, the pigmented
Articles • Developmental toxicity of chlorpyrifos and dieldrin
Environmental Health Perspectives • VOLUME 109 | NUMBER 7 | July 2001 655
Figure 5. Effects of chlorpyrifos introduced at the
late blastula 1 stage (30 hr after fertilization, 10°C)
on the development of sea urchin S. droe-
bachiensis. (A) Chlorpyrifos 40 µM, 55 hr after fer-
ti l ization. (B) Chlorpyrifos 5 µM, 55 hr after
fertilization. (C) Chlorpyrifos 40 µM + AA-DMAE 40
µM, 55 hr after fertilization; note almost full pro-
tection (early prism stage). Structural features: 1,
very small nontransformed part of larva
enveloped by (2) pigmented extralarval cells; 3,
dark cells accumulated in the blastocele; 4,
archenteron. Scale bar = 100 µm.
Figure 6. Effects of chlorpyrifos introduced at the
late blastula 2 stage (32 hr after fertilization, 10°C)
on the development of sea urchin S. droebachien-
sis. (A) Chlorpyrifos 25 µM, 50 hr after fertilization.
(B) Chlorpyrifos 15 µM, 50 hr after fertilization. (C)
Chlorpyrifos 25 µM + AA-DMAE 40 µM, 50 hr after
fertilization; note clear protection (mid-gastrula
stage; moderate retardation of development).
Structural features: 1, extralarval conglomerate of
pigmented cells (“cap”); 2, archenteron, normal
gastrulation; 2a, archenteron; exogastrulation; 3,
blastopore). Scale bar = 50 µm.
cells that arose 5–6 hr after addition of chlor-
pyrifos accumulated inside the larva (Figure
5B), rather than in an external cap. Later,
these larvae also began to exogastrulate (cate-
gory I, seen near the threshold concentration).
This defect thus culminated in a different
structural outcome, despite the fact that the
same type of cellular anomaly was obtained as
at the higher concentrations. Lower concen-
trations of chlorpyrifos did not perturb larval
development up to the beginning of active
feeding (category 0, no effect). The types of
defects and their concentration dependence
were highly reproducible across different
batches of embryos and larvae and across the
two species examined (Tables 1 and 2).
Up to this point, the description of
defects pertains to those observed after expo-
sure was begun during the developmental
stages most sensitive to chlorpyrifos (mid-
blastula 2 to late blastula 1). These categories
of defects can also be used to describe
responses elicited during the less-sensitive
periods preceding and following the sensitive
period. Adding chlorpyrifos at the one-cell
stage, even at the highest concentrations
(40–160 µM), had no initial effect, and
abnormalities did not appear until the mid-
blastula stage (Figure 7A, Tables 1 and 2).
Some of these embryos remained normal at
the mid-blastula 2 stage (category 0), whereas
others exhibited anomalies: inhibition of
hatching, precocious appearance of mes-
enchyme cells in the blastocele, and extrusion
of some cells to the perivitelline space (Figure
7C, 8A). These defects (ranging across all
four categories) were concentration-depen-
dent (Tables 1 and 2); for example, the num-
ber of cells extruded into the perivitelline
space varied for different chlorpyrifos con-
centration from single (category I) or few
(category II, Figure 7C) to half or a majority
of cells (categories III–IV, Figure 8A). In the
embryos that hatched, cell extrusion and cap-
like malformations were evident, incorporat-
ing most larval cells, as described earlier
(Figure 7E). The caps were clearly delimited
from the larvae (compare Figure 7E to Figure
6A or 9C) and were usually lost at the time
that control larvae reached the prism stage.
The blastopore and archenteron were visible
in the diminished vegetal half of chlorpyrifos-
treated larvae. There were no exogastrulae
with this treatment regimen, so these
embryos were capable of normal gastrula-
tion. In the embryo population that failed to
hatch (comprising all the embryos when the
chlorpyrifos concentration was raised to
80–160 µM), extrusion of abnormal cells
continued into the perivitelline space (Figure
8A, category IV). These cells did not form
the compact cap and were instead suspended
in the perivitelline fluid, moving inside the
fertilization membrane with rotation of the
blastula. The embryos of the nonhatching
population were unable to achieve gastrula-
tion and thus were ultimately nonviable.
In keeping with the concept that initial
stages of development are relatively unaf-
fected by chlorpyrifos treatment, the thresh-
old concentration for adverse effects added
immediately after fertilization (> 10 µM) was
higher than that described above for exposure
during subsequent developmental stages.
However, we also obtained evidence for clo-
sure of the critical period for the effects of
chlorpyrifos: The sensitivity began to
decrease simultaneously with gastrulation;
the threshold concentration necessary to elicit
anomalies rose sequentially to more than 10
µM (Tables 1 and 2). When chlorpyrifos was
introduced at the mid or late gastrula stage,
the extrusion of cells started almost immedi-
ately during the next 1–2 hr. At this stage,
the extruded cells were semitransparent and
did not form a compact cap. Rather, they
assembled into loose clusters to form a
plume-like shape (Figure 8C), comprising a
much smaller proportion (~15–30%) of total
larval cells. These larvae were nonviable at 80
µM chlorpyrifos (category IV in this group of
experiments) or, at slightly lower concentra-
tions (40 µM, category III), survived for the
next 1–3 days (Tables 1 and 2). Cells of the
latter group were shed continuously and the
plume finally became separated from the
motile larva, leaving behind an unusually pig-
mented animal part, considerably broadened
compared to the transparent vegetative part.
By decreasing the chlorpyrifos concentration
further, to 15–20 µM (Tables 1 and 2), we
obtained larvae with a smaller plume (category
II) or with cells accumulated inside the blas-
tocele without extrusion (category I).
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Figure 7. Effects of chlorpyrifos introduced at the one-cell stage (30 min after fertilization, 10°C) on the
development of sea urchin S. droebachiensis. (A) Chlorpyrifos 160 µM. (B) Control. Both (A) and (B) pic-
tures taken 8 hr 45 min after fertilization. (C) Chlorpyrifos 40 µM. (D) Control. Both (C) and (D) pictures
taken 21 hr 25 min after fertilization. (E) Chlorpyrifos 40 µM. (F) Control. Both (E) and (F) pictures taken at
64 hr 30 min after fertilization. Structural features: 1, precocious accumulation of cells in the blastocele; 2,
extralarval conglomerate of pigmented cells (“cap”); 3, dwarf larva (stem of mushroom-like formation).
Scale bar = 50 µm.
Finally, chlorpyrifos, added at the
higher threshold required for effects at the
prism stage or later (~15–20 µM), did not
evoke cell extrusion, but nevertheless con-
tinued to kill larvae, indicating additional
toxic mechanisms unrelated to the types
of developmental anomalies described for
earlier stages. We have not yet evaluated
the potentia l  morphological  defects
accompanying this late stage of chlorpyri-
fos exposure.
Chlorpyrifos metabolites. We conducted
additional studies (6 series on S. droe-
bachiensis and 3 series on S. purpuratus) to
test the actions of chlorpyrifos metabolites:
chlorpyrifos oxon, the active metabolite that
inhibits cholinesterase and is thus responsi-
ble for the acute toxicity of chlorpyrifos, and
3,5,6-trichloropyridinol, the main catabolic
product of chlorpyrifos. Neither of these
metabolites (40–80 µM), added immediately
after fertilization or at the mid-blastula 2
stage (when the sensitivity to chlorpyrifos
was the highest), evoked any developmental
anomalies (Figure 9). To ensure that the
negative findings for chlorpyrifos oxon did
not reflect chemical degradation of the com-
pound in ASW, we evaluated its stability
under our incubation conditions. High-per-
formance liquid chromatographic analysis
(57) of 40 mM chlorpyrifos oxon incubated
with ASW for up to 24 hr indicated
absolutely no breakdown for at least 24 hr
(no further measures were taken).
Antagonism of the effects of chlorpyrifos.
If chlorpyrifos elicits developmental anom-
alies through effects on cholinergic receptors
or signaling cascades linked to the receptors,
then antagonists should prevent or augment
the effects. The hydrophilic nAChR antago-
nists imechine and QX-222 (25–50 µM)
produced partial protection from the adverse
effects of chlorpyrifos, whereas lipophilic
antagonists capable of penetrating the cell
membrane, AA-DMAE or DHA-DMAE
(20–40 µM), reduced or prevented all the
developmental anomalies (Figures 5, 6, 8). In
additional studies, we found that these antag-
onists protected the late larvae (prism and
pluteus stages) from chlorpyrifos-induced
lethality. The muscarinic acetylcholine recep-
tor antagonist atropine (10–100 µM) did not
change the sensitivity of sea urchin larvae to
chlorpyrifos (experiments on S. droebachiensis
only; data not shown).
We next evaluated inhibitors acting on
signaling cascades downstream from the
receptors. HA-1004, a PKA inhibitor, did
not influence the adverse effects of chlorpyri-
fos (Figure 10) but H-7, a PKC inhibitor,
potentiated chlorpyrifos’ actions. In the pres-
ence of H-7 (10–20 µM), 10 µM chlorpyri-
fos elicited actions approximating those seen
with a higher concentration (40 µM) of
chlorpyrifos alone (Figure 10B, compared to
Figure 5A). Although these concentrations
of H-7 had no effect on the embryos by
themselves (Figure 10D), they are fully effec-
tive in preventing teratogenic actions of
phorbol 12-myristate 13-acetate and other
PKC activators (47).
We observed a similar pattern when
chlorpyrifos was added after fertilization.
AA-DMAE and DHA-DMAE protected
the embryos, even if they were added at the
early blastula 2 to mid-blastula 1 stages,
10–12 hr after chlorpyrifos. HA-1004 did
not change the sensitivity to chlorpyrifos
when the latter compound was added after
fertilization, whereas again H-7 increased
the sensitivity. In these results, as in the
studies with chlorpyrifos alone, sea urchin
embryos were relatively insensitive during
cleavage divisions and blastulation, but dis-
played high sensitivity at the mid-blastula
2 stage.
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Figure 8. Effects of chlorpyrifos on the development of sea urchin S. droebachiensis. In (A) and (B), the
substances were introduced at the one-cell stage (30 min after fertilization); videotaping was made 37 hr
after fertilization. (A) Chlorpyrifos 160 µM. (B) Chlorpyrifos 160 µM + DHA-DMAE 40 µM; note almost com-
plete protection (very beginning of gastrulation). In (C) and (D), the substances were introduced at the
late gastrula stage (43 hr after fertilization); the videotaping was made 64 hr after fertilization. (C)
Chlorpyrifos 40 µM. (D) Chlorpyrifos 40 µM + DHA-DMAE 40 µM; note protection (prism stage). Structural
features: 1, the fertilization envelope; 2, extralarval cells in the perivitelline space; 3, broadened animal
half of larva; 4, blastopore; 5, narrowed vegetative part of larva; 6, extralarval conglomerate of cells
(“plume”); 7, intrablastocele conglomerate of pigmented cells near the vegetative part of archenteron (a
feature never seen in control larvae). Scale bar = 50 µm.
Discussion
The present results indicate that sea urchin
embryos and larvae represent a promising
invertebrate model system for the evalua-
tion of developmental neurotoxicity of
organophosphate pesticides, with regard to
both screening procedures and mechanistic
investigations. Sea urchins produce numer-
ous offspring that develop rapidly and with
a specified sequence of morphological
events that are readily apparent with rou-
tine microscopy. Adverse effects as seen here
occur in a nearly all-or-none manner, with a
very sharp demarcation between normal and
abnormal embryos. Importantly, just like the
mammalian CNS, the sea urchin expresses
nAChRs that are linked to cell replication,
differentiation, and apoptosis; so in this
species, xenobiotic effects on cholinergic sig-
naling are reflected by easily observable dys-
morphogenesis, whereas comparable effects
in the developing brain tend to elicit more
subtle alterations that entail biochemical and
functional assessments (1–3,39,42–47,49).
In the case of chlorpyrifos, our findings for
the underlying mechanisms and critical
period of vulnerability in sea urchins are
consistent, as discussed below, with the dual
aspect of this pesticide’s actions on mam-
malian CNS development, comprising both
cholinergic and noncholinergic components
(3,8,9,11,12,14,16,19).
In the developing mammalian brain, the
vulnerability to chlorpyrifos emerges coinci-
dentally with that of nAChR expression, so
that at the neural tube stage, interference
with mitosis and production of apoptosis
show a specified progression with nAChR
concentration (19,58). Subsequently, during
postnatal development, there are at least two
distinct effect classes. The first is indepen-
dent of cholinergic receptor expression and
influences cell replication through effects on
intracellular messengers (9,12,14). With the
progressive rise in receptor expression in
cholinergically enriched regions (59), a sec-
ond set of effects emerges, influencing cell
replication and neuritic outgrowth, that is
cholinergically related but nevertheless inde-
pendent of the generation of chlorpyrifos
oxon, the active metabolite that inhibits
cholinesterase (3,8,10,16). These findings
imply a direct interaction of chlorpyrifos with
cholinergic receptors and signaling cascades in
the developing mammalian CNS, consistent
with results obtained from in vitro examina-
tions of potential receptor targets (26,27,29).
With the present work in developing sea
urchins, chlorpyrifos elicited developmental
anomalies similar to those seen previously
for cholinergic receptor agonists (55) such as
nicotine (47). Hydrophilic nAChR antago-
nists that cannot penetrate the cell membrane
(imechine, QX-222), but not the muscarinic
acetylcholine receptor antagonist atropine,
produced partial protection from chlorpyrifos
treatment, implying that chlorpyrifos targets
nAChRs, proteins that are readily found on
the cell surface of sea urchin eggs, embryos,
and larvae (45,47,60,61). Furthermore, the
critical period of vulnerability to chlorpyrifos
corresponded to the onset of gastrulation,
coinciding with the beginning of neurotrans-
mitter regulation of the developing cells and
coordinated surges in acetylcholine and
receptor levels (41,44,45,49). Thus, it is not
just the presence or absence of the receptors
that dictates the vulnerability to chlorpyrifos,
but rather the cellular specification of recep-
tor expression and the developmental con-
text in which receptors are stimulated:
Before gastrulation, neurotransmitters
(including acetylcholine, serotonin, and
other monoamines) and their receptors are
expressed in all embryonic or larval cells
(44,45). It is only with the rise in concentra-
tion of neurotransmitters and receptors, and
their specialization into specific cell groups,
that vulnerability to chlorpyrifos becomes
apparent. Again, this finding parallels the
stage-specific effects of chlorpyrifos on mam-
malian brain development (3,8). Finally, we
were able to distinguish the relative impor-
tance of nAChRs as a potential target for
developmental disruption by pesticides, since
dieldrin, which targets GABAA receptors
(62), had little or no effect.
There are two different potential mecha-
nisms for the targeting of nAChRs by chlor-
pyrifos. If the organism produces chlorpyrifos
oxon, leading to inhibition of cholinesterase,
or if the chlorpyrifos concentration is high
enough to cause enzymatic inhibition by
itself (16), then endogenous cholinergic sig-
nals could be enhanced, producing inappro-
priate timing and intensity of trophic events
linked to cholinergic receptors. However, this
interpretation is entirely ruled out by our
finding that chlorpyrifos oxon was totally
ineffective in eliciting dysmorphogenesis.
Indeed, prior work with nonorganophos-
phate cholinesterase inhibitors also failed to
demonstrate interference with sea urchin
embryonic and larval development (41,49),
confirming the interpretation that cholines-
terase inhibition per se is relatively unimpor-
tant in mediating the adverse effects of
chlorpyrifos in this system. The second possi-
bility is that chlorpyrifos itself interacts with
nAChRs, eliciting cholinergic agonist-like
effects. Indeed, both chlorpyrifos and its
oxon interact with muscarinic cholinergic
receptors as well as nAChRs and related ion
channels (26–30). Thus, just like the devel-
oping mammalian CNS, chlorpyrifos targets
cholinergic receptors in sea urchin embryos,
leading to disruption of cellular differentia-
tion and corresponding dysmorphogenesis,
with a critical period delineated by emergence
of nAChRs. Accordingly, chlorpyrifos evokes
dysmorphogenesis through involvement of
cholinergic mechanisms that are separable
from inhibition of cholinesterase by itself or
by its active metabolite, chlorpyrifos oxon.
Notwithstanding the involvement of
membrane-associated nAChRs, chlorpyrifos
clearly has additional actions contributing to
altered development. Hydrophilic nAChR
blocking agents (imechine, QX-222) caused
only partial protection against the effects of
chlorpyrifos, implying the existence of intra-
cellular targets. In contrast, AA-DMAE and
DHA-DMAE, which penetrate the cell
membrane (55), provided complete protec-
tion from chlorpyrifos throughout all the
sensitive developmental stages, including late
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Figure 9. Effects of chlorpyrifos metabolites on
the development of sea urchin S. droebachiensis.
The substances were introduced at the mid-blas-
tula 2 stage (24 hr after fertilization); videotaping
was made 47 hr 30 min after ferti l ization.
(A) Trichloropyridinol 40 µM; normal late gastrula.
(B) Chlorpyrifos oxon 40 µM; normal late gastrula.
(C) chlorpyrifos 10 µM (given for comparison), dis-
playing typical mushroom-shaped formation.
Structural features: 1, “cap”; 2, dwarf larva
(“stem”). Scale bar = 50 µm.
larval stages (prisms and plutei). One possi-
bility, then, is that chlorpyrifos targets intra-
cellularly located nAChRs that may also play
a role in cell differentiation. Previous evi-
dence suggests that intracellular cholinergic
receptors are present in sea urchin eggs and
early embryos, and take part in triggering
cleavage divisions (44,45). However, these
early events lie outside the critical window
for the adverse effects of chlorpyrifos
observed here; we did not find any interfer-
ence with cleavage divisions. Furthermore, if
effects on nAChRs, whether on the cell sur-
face or intracellularly, were the only effect of
chlorpyrifos leading to dysmorphogenesis,
then chlorpyrifos oxon should have been
more effective, because it is at least as potent
toward receptors and ion channels as chlor-
pyrifos itself (29,30). 
The full spectrum of chlorpyrifos’ effects
may thus require the combination of nAChR
targeting, plus other, intracellular events
downstream from receptor activation.
Previous work in the developing mammalian
brain indicates that chlorpyrifos can interact
with proteins involved in signaling cascades
that transduce receptor signals (9,26–28).
Certainly, the lipophilic moieties present on
AA-DMAE and DHA-DMAE could extend
activity toward other sites besides intracellular
nAChRs, because the side chain of AA-
DMAE is arachidonic acid, a potent intra-
cellular messenger. In light of earlier work
with mammalian brain that indicated effects
of chlorpyrifos on PKA-related signaling cas-
cades (9,26–28), we conducted studies of the
interaction of chlorpyrifos with drugs known
to interfere with two of the most prominent
protein kinase-based signaling elements,
PKA and PKC. We found that whereas a
PKA inhibitor had no effect on the response
to chlorpyrifos, a PKC inhibitor enhanced
the ability of chlorpyrifos to disrupt embry-
onic and larval development. This suggests
that at least one of the secondary sites of
chlorpyrifos’ actions is at the level of PKC
activity. Again, this has a distinct parallel in
mammalian brain. Inhibition of PKC during
neurulation leads to dysmorphogenesis (63);
this is also the stage for emergence of the
effects of chlorpyrifos on mitosis and apop-
tosis. The concept that the net developmen-
tal effect of chlorpyrifos represents the
interaction of targeting of PKC with effects
mediated at the level of nAChRs is thus a
novel area for future research. Indeed, this is
precisely the point at which similar vulnera-
bility emerges to nicotine during mam-
malian brain development, the most obvious
nAChR-targeting prototype (58).
It is particularly interesting to note that
we did not find any exacerbation of the
effects of chlorpyrifos by a PKA inhibitor.
Earlier work with the mammalian brain sug-
gests that chlorpyrifos targets signaling cas-
cades converging on the formation of cyclic
AMP, including Gi- and Gs-linked recep-
tors, G-proteins themselves, and adenylyl
cyclase (9,26–28). It is obvious that this is
not the case in the sea urchin model, imply-
ing either that any effects on signaling medi-
ated through PKA occur “downstream”
from primary effects on other cascades (e.g.,
PKC) or that development in the sea urchin
does not provide an adequate model for this
particular aspect of chlorpyrifos’ actions on
mammalian brain. Again, future work will
be necessary to clarify this relationship.
In any case, the current results suggest
that examination of the role of PKC in differ-
ent stages of development of the mammalian
CNS is warranted; indeed, recent work with
phenobarbital and heroin suggests that neu-
robehavioral disruption by these agents also
originates in changes in the expression and
cholinergic responsiveness of PKC (64,65).
The membrane-permeable cholinergic
analogs described here, or chlorpyrifos itself,
may thus provide important tools for dissect-
ing the role of such intracellular mediators in
neural cell differentiation. Our results with
sea urchin embryos provide an initial glimpse
into the role of cholinergic signaling and
PKC in this process. The formation of an
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Figure 10. The effects of protein kinase inhibitors on the sensitivity of S. droebachiensis larvae to 10 µM chlor-
pyrifos; all substances were added at the late blastula 1 stage (32 hr after fertilization) and larvae were video-
taped 15 (A,C) or 19 (D) hr later. (A) Chlorpyrifos alone. (B) Chlorpyrifos + H-7 20 µM. (C) Chlorpyrifos + HA-1004
20 µM. (D) H-7 20 µM alone; late gastrula stage. Structural features: 1, extralarval conglomerate of pigmented
cells [“cap” (A,C) or “envelope” (B)]; 2, archenteron. Scale bar = 50 µm.
extralarval cell mass (mid-blastula stage) or
cluster (late blastula and gastrula stages) was
the most striking effect of chlorpyrifos. At
the very least, the extralarval mass and cell
extrusion both represent a major perturba-
tion of morphogenesis, but are not likely to
constitute simply an effect on cell prolifera-
tion or growth. Indeed, the extruded cells
suspended in the perivitelline fluid or con-
tained within the cap- or plume-like con-
glomerate were approximately the same size
as normal larval cells at that stage of develop-
ment. Given that the larva is not yet feeding,
additional cells cannot be produced without
a corresponding reduction in cell size, an
effect that was not seen in the chlorpyrifos-
treated group. Cell migration itself appears
not to be an actual target for the effects of
chlorpyrifos, because the movement of cells
continued in the normal direction along the
animal–vegetal axis, albeit that the cells were
migrating into the enormous extralarval cell
mass through an abnormal structure, the thin
stalk attached to the animal pole. The reverse
direction of cell movement (exogastrulation)
was seen in some experimental situations,
too, simultaneously with formation of the
extralarval cap (see, for example, Figure 4C).
Nevertheless, cells displaying altered mor-
phology and location accumulated in the
larva with or without subsequent extrusion
(illustrated in Figure 5B, showing the effects
of near-threshold chlorpyrifos concentra-
tions, and Figure 9C, where there is broaden-
ing of the animal part of chlorpyrifos-treated
larvae caused by transformed, pigmented
cells), so altered differentiation was not inex-
tricably linked to cell migration.
Results of this study suggest that chlor-
pyrifos exposure, mediated through its
effects on nAChRs and PKC, leads to a
change in cell phenotype, since there are no
pigmented cells in a normal embryo or larva
of this sea urchin species, rather than causing
a primary disruption of cell proliferation or
migration. This is followed by generalized
dysmorphology characterized by subsequent
cell extrusion and the formation of extralar-
val caps containing pigmented cells. Since
the extralarval caps can exceed 90% of the
total number of larval cells, it appears that
cells from different parts of the embryo or
larva undergo the transformation. This sug-
gests that the developmental targets of chlor-
pyrifos, including nAChRs and PKC, and
potentially the monoamines and their signal-
ing cascades (9,21,22), represent primary
sites for regulation of cell phenotype. As
well, our results address the time frame in
which these processes are likely to control
cell fate. In the sea urchin, this corresponds
to the mid-blastula stage, the point at which
the maternal genome is turned off and the
embryonic (zygotic) genome is turned on
(43–46,51). That this phenomenon is con-
nected to compartmentalized augmentation
of cholinergic signaling implies that the sea
urchin embryo may ultimately provide us
with the tools to characterize the molecular
events underlying the neuroteratogenesis of a
wide variety of drugs and environmental
agents that converge on cholinergic signals
or their downstream signaling cascades.
There are, of course, limitations to the
use of the sea urchin as a potential model for
screening and mechanistic studies of pesti-
cide effects on mammalian CNS develop-
ment. The sea urchin, like culture-based
models, cannot elucidate the importance of
maternal–fetal pharmacokinetics and metab-
olism in determining the concentration of
neuroteratogens that reach the fetus.
Accordingly, the thresholds necessary to elicit
effects in sea urchins cannot provide an
absolute guide to the appropriate calculation
of exposure limits for regulatory purposes. On
the other hand, the sensitivity of sea urchin
embryos seen here is quite comparable to that
with in vitro mammalian models, such as
whole embryos, neuronal cell lines, or CNS
cultures (11,12,14–19,31–34). Nevertheless,
our results point to potential utility of this or
similar invertebrate model systems to screen
compounds for potential neuroteratogenic
activity in a comparative manner [as done
here for chlorpyrifos, chlorpyrifos oxon, and
dieldrin, and in a preliminary study for diazi-
non (66)], and to help identify heretofore
unsuspected cellular targets underlying neu-
robehavioral teratogenesis.
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